Intuitive Surgical (ISRG) Stock May Be Fairly Valued On New Robotics Competition

Intuitive Surgical has rewarded patient shareholders over the past few years. With the share price at US$427.86 and fresh competition emerging, the real issue is whether that valuation is still grounded in the cash the business can generate. Over the past 3 years the stock has gained 56.5%. This puts real pressure on the question of how far its future cash flows can stretch to support that climb. Johnson & Johnson's FDA cleared OTTAVA system introduces a new rival in robotic surgery. This...